Literature DB >> 11846419

Cloning and expression of a full-length cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase B.

Valérie Dewaste1, Dirk Roymans, Colette Moreau, Christophe Erneux.   

Abstract

Inositol 1,4,5-trisphosphate (InsP(3)) 3-kinase catalyzes the phosphorylation of InsP(3) to inositol 1,3,4,5-tetrakisphosphate (InsP(4)). cDNAs encoding three isoenzymes of InsP(3) 3-kinase (3-kinases A, B, and C) have been previously reported; however, a demonstrably full-length cDNA encoding human InsP(3) 3-kinase B was still lacking. Here we report the cloning of a full-length 2841-bp cDNA encoding human InsP(3) 3-kinase B. Northern blot analysis shows the presence of an ubiquitous transcript of approximately 7.2 kb in a large number of human tissues. InsP(3) 3-kinase activity measured in COS-7 cells transfected with InsP(3) 3-kinase B shows an activity that was 8-fold increased upon the addition of Ca(2+)/calmodulin in the assay mixture. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846419     DOI: 10.1006/bbrc.2002.6456

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Regulation of the localization and activity of inositol 1,4,5-trisphosphate 3-kinase B in intact cells by proteolysis.

Authors:  Jowie C H Yu; Samantha M Lloyd-Burton; Robin F Irvine; Michael J Schell
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 2.  Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types.

Authors:  Sabine Windhorst; Kai Song; Adi F Gazdar
Journal:  Biochem Pharmacol       Date:  2017-04-02       Impact factor: 5.858

3.  Human inositol 1,4,5-trisphosphate 3-kinase isoform B (IP3KB) is a nucleocytoplasmic shuttling protein specifically enriched at cortical actin filaments and at invaginations of the nuclear envelope.

Authors:  Marcus M Nalaskowski; Ralf Fliegert; Olga Ernst; Maria A Brehm; Werner Fanick; Sabine Windhorst; Hongying Lin; Susanne Giehler; Jamin Hein; Yuan-Na Lin; Georg W Mayr
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

Review 4.  Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils.

Authors:  Hongbo R Luo; Subhanjan Mondal
Journal:  EMBO Rep       Date:  2015-01-09       Impact factor: 8.807

5.  Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity.

Authors:  Ben G Wen; Mathew T Pletcher; Masaki Warashina; Sun Hui Choe; Niusha Ziaee; Tim Wiltshire; Karsten Sauer; Michael P Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

6.  Identification of the actin-binding domain of Ins(1,4,5)P3 3-kinase isoform B (IP3K-B).

Authors:  Maria A Brehm; Isabell Schreiber; Uwe Bertsch; Albrecht Wegner; Georg W Mayr
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

7.  Modulation of Epidermal Growth Factor Stimulated ERK Phosphorylation and Cell Motility by Inositol Trisphosphate Kinase.

Authors:  M C Sekar; K Shahiwala; L Leloup; A Wells
Journal:  J Pharm Sci Pharmacol       Date:  2014-06-01

8.  The three isoenzymes of human inositol-1,4,5-trisphosphate 3-kinase show specific intracellular localization but comparable Ca2+ responses on transfection in COS-7 cells.

Authors:  Valérie Dewaste; Colette Moreau; Florence De Smedt; Françoise Bex; Humbert De Smedt; Frank Wuytack; Ludwig Missiaen; Christophe Erneux
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  Inositol trisphosphate 3-kinase B (InsP3KB) as a physiological modulator of myelopoiesis.

Authors:  Yonghui Jia; Fabien Loison; Hidenori Hattori; Yitang Li; Christophe Erneux; Shin-Young Park; Chong Gao; Li Chai; Leslie E Silberstein; Stephane Schurmans; Hongbo R Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

Review 10.  Inositol trisphosphate 3-kinases: focus on immune and neuronal signaling.

Authors:  Michael J Schell
Journal:  Cell Mol Life Sci       Date:  2010-01-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.